Nisa Investment Advisors
PTGX icon

Nisa Investment Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Nisa Investment Advisors’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Buy
3,802
+22
+0.6% +$1.95K ﹤0.01% 1027
2025
Q4 		$330K Sell
3,780
-205
-5% -$16.8K ﹤0.01% 1113
2025
Q3 		$265K Buy
3,985
+82
+2% +$4.66K ﹤0.01% 1182
2025
Q2 		$216K Buy
3,903
+1,071
+38% +$51.4K ﹤0.01% 1199
2025
Q1 		$137K Sell
2,832
-301
-10% -$12.6K ﹤0.01% 1321
2024
Q4 		$121K Buy
3,133
+295
+10% +$12.9K ﹤0.01% 1422
2024
Q3 		$128K Buy
2,838
+93
+3% +$3.76K ﹤0.01% 1378
2024
Q2 		$95.1K Buy
2,745
+54
+2% +$1.58K ﹤0.01% 1491
2024
Q1 		$77.9K Buy
2,691
+52
+2% +$1.42K ﹤0.01% 1548
2023
Q4 		$60.5K Hold
2,639
– – ﹤0.01% 1593
2023
Q3 		$44K Hold
2,639
– – ﹤0.01% 1761
2023
Q2 		$72.9K Buy
2,639
+590
+29% +$14.8K ﹤0.01% 1616
2023
Q1 		$47K Hold
2,049
– – ﹤0.01% 1735
2022
Q4 		$22K Buy
2,049
+49
+2% +$413 ﹤0.01% 2037
2022
Q3 		$16K Hold
2,000
– – ﹤0.01% 2101
2022
Q2 		$16K Sell
2,000
-24,390
-92% -$295K ﹤0.01% 2100
2022
Q1 		$625K Sell
26,390
-760
-3% -$21.4K ﹤0.01% 1008
2021
Q4 		$795K Buy
27,150
+26,700
+5,933% +$844K 0.01% 894
2021
Q3 		$8 Hold
450
– – ﹤0.01% 2230
2021
Q2 		$20 Hold
450
– – ﹤0.01% 2138
2021
Q1 		$12 Hold
450
– – ﹤0.01% 2189
2020
Q4 		$9K Buy
+450
New +$9.69K ﹤0.01% 2220

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Nisa Investment Advisors's PTGX Position: Q1 2026 in Review

Nisa Investment Advisors increased its Protagonist Therapeutics (PTGX) stake by 0.58% in Q1 2026, buying an estimated $1.95K and bringing the position to 3,802 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

Nisa Investment Advisors first reported a position in PTGX in Q4 2020 and has held it in 22 quarters since. The position peaked at $795K in Q4 2021. 319 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • Nisa Investment Advisors held 3,802 shares of Protagonist Therapeutics worth $401K as of Q1 2026.
  • Nisa Investment Advisors bought 22 Protagonist Therapeutics shares in Q1 2026, an estimated $1.95K.
  • Protagonist Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1027 holding.
  • Nisa Investment Advisors first reported a position in Protagonist Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Nisa Investment Advisors's Protagonist Therapeutics position peaked at $795K in Q4 2021.
  • 319 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.